Organoids revolutionizing precancer research

Area of Science:

• Cancer Research
• Biomedical Engineering
• Translational Medicine

Background:

• Precancerous lesions are critical for early cancer detection but are challenging to study due to limited samples and molecular heterogeneity.
• Traditional models fail to replicate the in vivo complexity of precancerous lesions.
• Organoids offer a patient-specific, in vitro model that preserves key pathological features.

Purpose of the Study:

• To review advancements in organoid-based modeling of precancerous lesions.
• To summarize organoid construction, validation, and applications in precancer research.
• To highlight integrative approaches for enhanced organoid systems.

Main Methods:

• Systematic review of recent literature on organoid technology in precancer research.
• Focus on organoid construction strategies and validation frameworks.
• Integration of CRISPR-Cas9 genome editing and single-cell multi-omics.

Main Results:

• Organoids provide faithful models for studying precancerous lesion evolution.
• Organoid applications include biomarker discovery and therapeutic screening for precision prevention.
• Integrative approaches improve organoid fidelity, scalability, and clinical relevance.

Conclusions:

• Organoid technology is revolutionizing precancer research by bridging basic science and clinical application.
• Organoids offer unprecedented tools for early detection, risk stratification, and personalized cancer prevention.
• This technology facilitates a deeper understanding of tumorigenesis and enables novel therapeutic strategies.